MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...
MSD Ireland's robust R&D pipeline of therapeutic projects ensures it is ready to meet the diverse needs of patients globally ...
Hosted on MSN2mon
WuXi Biologics to sell Ireland-based vaccine site to MSD for $500mWuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback